Genomics Market Sees Sustained Growth Driven by Declining DNA Sequencing Costs and Technological Advancements
The genomics market is experiencing continuous growth, primarily due to the decreasing cost of DNA sequencing and ongoing innovations in next-generation sequencing (NGS) technologies. This increased affordability has led to a broader adoption of various sequencing methods, including whole-genome sequencing (WGS), whole-exome sequencing (WES), targeted sequencing, and transcriptome analysis. These technologies are being applied across diverse fields such as oncology, rare disease diagnosis, reproductive health, pharmacogenomics, and infectious disease surveillance. Government initiatives, like the National Institutes of Health (NIH) All of Us Research Program, and substantial funding for genomic research are further accelerating the integration of genomics into disease prevention, personalized medicine, and population health studies. The market expansion is also fueled by rising investments in precision medicine and personalized healthcare, alongside continuous reductions in sequencing costs and advancement... 
